Roundtables

15 Aug RNAi Roundtable: Lumasiran, in Development for the Treatment of Primary Hyperoxaluria Type 1

On August 15, 2018, we hosted an online RNAi Roundtable to review the progress with lumasiran, an RNAi therapeutic in development for the treatment of primary hyperoxaluria type 1. Access the replay View the presentation Read the transcript

24 Jul RNAi Roundtable: Givosiran, in Development for the Treatment of Acute Hepatic Porphyrias

On July 24, 2018, we hosted an online RNAi Roundtable to review the progress with givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyrias. Access the replay View the presentation Read the transcript

21 Jun 2018 Summer RNAi Roundtable Series

We are hosting a series of online "RNAi Roundtables" from June through September, at which Alnylam scientists, clinical collaborators, and patients or patient advocates review recent progress in many of the Company's late-stage pipeline programs and discuss the related disease areas.